Reduced contractile response to α1-adrenergic stimulation in atria from mice with chronic cardiac calmodulin kinase II inhibition

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 3, 2007, Pages 643-652

  Grimm, Michael ^a   El Armouche, Ali ^a   Zhang, Rong ^b   Anderson, Mark E ^c   Eschenhagen, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Alpha1 adrenergic; Cam Kinase; Heart contractility; Post rest potentiation

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; PHENYLEPHRINE; PROTEIN KINASE (CALCIUM,CALMODULIN);

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; HEART ATRIUM FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; LEISURE; MOUSE; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

AMIDES; ANIMALS; BORON COMPOUNDS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; HEART; MICE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PHENYLEPHRINE; PROTEIN KINASE INHIBITORS; PYRIDINES; RECEPTORS, ADRENERGIC, ALPHA; TIME FACTORS;

MUS;

EID: 33847381124     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.12.010     Document Type: Article

References (42)

1. Lip G.Y. The left atrium in hypertension, an appendage often forgotten. J. Hum. Hypertens 11 (1997) 145-147
2. Hoit B.D., and Gabel M. Influence of left ventricular dysfunction on the role of atrial contraction: an echocardiographic-hemodynamic study in dogs. J. Am. Coll Cardiol. 36 (2000) 1713-1719
3. ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 283 (2000) 1967-1975
4. Grimm M., Haas P., Willipinski-Stapelfeldt B., Zimmermann W.H., Rau T., Pantel K., et al. Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the alpha 1-adrenergic positive inotropic effect in human atrium. Cardiovasc. Res. 65 (2005) 211-220
5. Andersen G.G., Qvigstad E., Schiander I., Aass H., Osnes J.B., and Skomedal T. alpha(1)-AR-induced positive inotropic response in heart is dependent on myosin light chain phosphorylation. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H1471-H1480
6. + exchange to the positive inotropic effect of phenylephrine, endothelin-3 and angiotensin II in rabbit ventricular myocardium. Naunyn Schmiedebergs Arch. Pharmacol. 355 (1997) 87-96
7. Kushida H., Hiramoto T., and Endoh M. The preferential inhibition of alpha 1- over beta-adrenoceptor-mediated positive inotropic effect by organic calcium antagonists in the rabbit papillary muscle. Naunyn Schmiedebergs Arch. Pharmacol. 341 (1990) 206-214
8. 2+ transient and contraction in single rat cardiomyocytes. J. Mol. Cell Cardiol. 24 (1992) 809-820
9. Endoh M. Signal transduction and Ca(2+) signaling in intact myocardium. J. Pharmacol. Sci. 100 (2006) 525-537
10. Grimm M., Mahnecke N., Soja F., El-Armouche A., Haas P., Treede H., et al. The MLCK-mediated alpha(1)-adrenergic inotropic effect in atrial myocardium is negatively modulated by PKCepsilon signaling. Br. J. Pharmacol. 148 (2006) 991-1000
11. Anderson M.E. Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias. Pharmacol. Ther. 106 (2005) 39-55
12. Li L., Satoh H., Ginsburg K.S., and Bers D.M. The effect of Ca(2+)-calmodulin-dependent protein kinase II on cardiac excitation-contraction coupling in ferret ventricular myocytes. J. Physiol. 501 Pt. 1 (1997) 17-31
13. Wu Y., Colbran R.J., and Anderson M.E. Calmodulin kinase is a molecular switch for cardiac excitation-contraction coupling. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2877-2881
14. Zhang R., Khoo M.S., Wu Y., Yang Y., Grueter C.E., Ni G., et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat. Med. 11 (2005) 409-417
15. Simmerman H.K., and Jones L.R. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol. Rev. 78 (1998) 921-947
16. Bassani J.W., Yuan W., and Bers D.M. Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am. J. Physiol. Cell Physiol. 268 (1995) C1313-C1319
17. Bers D.M. SR Ca loading in cardiac muscle preparations based on rapid-cooling contractures. Am. J. Physiol. Cell Physiol. 256 (1989) C109-C120
18. Kadambi V.J., Ball N., Kranias E.G., Walsh R.A., and Hoit B.D. Modulation of force-frequency relation by phospholamban in genetically engineered mice. Am. J. Physiol. Heart Circ. Physiol. 276 (1999) H2245-H2250
19. Palakodeti V., Oh S., Oh B.H., Mao L., Hongo M., Peterson K.L., et al. Force-frequency effect is a powerful determinant of myocardial contractility in the mouse. Am. J. Physiol. Heart Circ. Physiol. 273 (1997) H1283-H1290
20. 2+ sensitivity in failing hearts. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H637-H646
21. Remus T.P., Zima A.V., Bossuyt J., Bare D.J., Martin J.L., Blatter L.A., et al. Biosensors to measure inositol 1,4,5-trisphosphate concentration in living cells with spatiotemporal resolution. J. Biol. Chem. 281 (2006) 608-616
22. 3)-receptor type 2-deficient mice. Circ. Res. 96 (2005) 1274-1281
23. Bare D.J., Kettlun C.S., Liang M., Bers D.M., and Mignery G.A. Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase. J. Biol. Chem. 280 (2005) 15912-15920
24. 2+ mediated through alpha- and beta-adrenoceptors. Circ. Res. 62 (1988) 247-265
25. Nishimaru K., Tanaka Y., Tanaka H., and Shigenobu K. Inhibition of agonist-induced positive inotropy by a selective Rho-associated kinase inhibitor, Y-27632. J. Pharmacol. Sci. 92 (2003) 424-427
26. 2+/calmodulin-dependent PK II (CaMKII) activation in rat ventricular myocytes. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9400-9405
27. Bartel S., Vetter D., Schlegel W.P., Wallukat G., Krause E.G., and Karczewski P. Phosphorylation of phospholamban at threonine-17 in the absence and presence of beta-adrenergic stimulation in neonatal rat cardiomyocytes. J. Mol. Cell Cardiol. 32 (2000) 2173-2185
28. ++/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart. J. Pharmacol. Exp. Ther. 287 (1998) 996-1006
29. i-frequency relationships in rat ventricular trabeculae at physiological frequencies. Am. J. Physiol. Heart Circ. Physiol. 276 (1999) H9-H18
30. Kassiri Z., Myers R., Kaprielian R., Banijamali H.S., and Backx P.H. Rate-dependent changes of twitch force duration in rat cardiac trabeculae: a property of the contractile system. J. Physiol. 524 Pt. 1 (2000) 221-231
31. Wu Y., Shintani A., Grueter C., Zhang R., Hou Y., Yang J., et al. Suppression of dynamic Ca(2+) transient responses to pacing in ventricular myocytes from mice with genetic calmodulin kinase II inhibition. J. Mol. Cell Cardiol. 40 (2006) 213-223
32. Maier L.S., Bers D.M., and Pieske B. Differences in Ca(2+)-handling and sarcoplasmic reticulum Ca(2+)-content in isolated rat and rabbit myocardium. J. Mol. Cell Cardiol. 32 (2000) 2249-2258
33. Li L., Chu G., Kranias E.G., and Bers D.M. Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects. Am. J. Physiol. Heart Circ. Physiol. 274 (1998) H1335-H1347
34. Hagemann D., Kuschel M., Kuramochi T., Zhu W., Cheng H., and Xiao R.P. Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes. J. Biol. Chem. 275 (2000) 22532-22536
35. DeSantiago J., Maier L.S., and Bers D.M. Frequency-dependent acceleration of relaxation in the heart depends on CaMKII, but not phospholamban. J. Mol. Cell Cardiol. 34 (2002) 975-984
36. Picht E., Desantiago J., Huke S., Kaetzel M.A., Dedman J.R., and Bers D.M. CaMKII inhibition targeted to the sarcoplasmic reticulum inhibits frequency-dependent acceleration of relaxation and Ca(2+) current facilitation. J. Mol. Cell Cardiol. 42 (2006) 196-205
37. Endoh M., and Schümann H.J. Frequency-dependence of the positive inotropic effect of methoxamine and naphazoline mediated by alpha-adrenoceptors in the isolated rabbit papillary muscle. Naunyn Schmiedebergs Arch. Pharmacol. 287 (1975) 377-389
38. Deng X.F., Mulay S., and Varma D.R. Role of Ca(2+)-independent PKC in alpha 1-adrenoceptor-mediated inotropic responses of neonatal rat hearts. Am. J. Physiol. 273 (1997) H1113-H1118
39. Endoh M., Norota I., Takanashi M., and Kasai H. Inotropic effects of staurosporine, NA 0345 and H-7, protein kinase C inhibitors, on rabbit ventricular myocardium: selective inhibition of the positive inotropic effect mediated by alpha 1-adrenoceptors. Jpn. J. Pharmacol. 63 (1993) 17-26
40. Endou M., Hattori Y., Tohse N., and Kanno M. Protein kinase C is not involved in alpha 1-adrenoceptor-mediated positive inotropic effect. Am. J. Physiol. 260 (1991) H27-H36
41. 2+/calmodulin-dependent protein kinase II is phosphorylated by protein kinase C in vitro. Biochemistry 32 (1993) 2923-2930
42. 2+/Calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes. Circ. Res. 99 (2006) 398-406